Luisa María Villar

Universidad de Alcalá

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (13)

Avril Robertson

Affiliate Professor

University of Queensland

AUSTRALIA

View details

Angel Torrado-Carvajal

Assistant Professor

Universidad Rey Juan Carlos

SPAIN

View details

Enric Monreal

Healthcare professional

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

View details

Eduardo Aguera-Morales

Profesor Asociado

Universidad de Córdoba

SPAIN

View details

Francisco Pérez-Miralles

Associate Lecturer in Anatomy, Physiology and Neurology of voice, speech and language

University of Valencia

SPAIN

View details

Javier Caballero-Villarraso

SPAIN

View details

Jan Lunemann

Professor

University of Münster

GERMANY

View details

Manuel Comabella

SPAIN

View details

Rucsanda Pinteac

Vall d'Hebron Institut de Recerca

SPAIN

View details

Maria Buxó Pujolràs

Institut de Recerca Biomèdica de Lleida

SPAIN

View details

Koen Vandenbroeck

Ikerbasque Research Professor / Dir. Neurogenomiks

Ikerbasque, Basque Foundation for Science

SPAIN

View details

Konrad Rejdak

Medical University of Lublin

POLAND

View details

Jose L. Luque-Garcia

Assistant Professor

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luisa María Villar

Research Interests

Explore related searches

Contact this professor

Articles (19)

Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing–Remitting Multiple Sclerosis with Cognitive Impairment

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis

Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile

Serum biomarkers at disease onset for personalized therapy in multiple sclerosis

Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults

MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention

Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis

Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers

Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non‐cell‐autonomous neuronal damage

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

Collaborators (13)

Avril Robertson

Angel Torrado-Carvajal

Enric Monreal

Eduardo Aguera-Morales

Francisco Pérez-Miralles

Javier Caballero-Villarraso

Jan Lunemann

Manuel Comabella

Rucsanda Pinteac

Maria Buxó Pujolràs

Koen Vandenbroeck

Konrad Rejdak

Jose L. Luque-Garcia

Make your next move.